Previous Article | Next Article ![]()
Applied and Environmental Microbiology, December 2005, p. 8920-8924, Vol. 71, No. 12
0099-2240/05/$08.00+0 doi:10.1128/AEM.71.12.8920-8924.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
| SHORT REPORT |
Institute of Biochemistry and Molecular Biology, University of Freiburg, Hermann Herder Str. 7, 79104 Freiburg, Germany
Received 23 June 2005/ Accepted 3 September 2005
|
|
|---|
|
|
|---|
Most of the Arthrobacter genes characterized so far have been cloned and expressed in Escherichia coli (10, 15-17) and other bacterial hosts (16, 18, 19), or alternatively, the proteins have been purified directly from crude lysates of Arthrobacter. Heterologous expression, however, can lead to inactive proteins due to misfolding, a lack of appropriate enzyme cofactors and proper insertion of these cofactors into apoenzymes, or posttranslational modifications. The development of an Arthrobacter expression system would be beneficial for the production of active Arthrobacter enzymes, for use in genetic complementation assays, or for the engineering of Arthrobacter strains with new, biotechnologically significant catabolic features.
Our laboratory has investigated protein biochemistry and nicotine degradation in Arthrobacter nicotinovorans for over 2 decades. A large catabolic plasmid, pAO1, confers on Arthrobacter nicotinovorans the ability to degrade nicotine (3). Various enzymes of the nicotine degradation pathway in A. nicotinovorans (1, 3, 4) have been identified and characterized, and recently the sequencing of the 165-kb pAO1 plasmid was completed (8). We have previously cloned and biochemically characterized the 6-D-hydroxynicotine oxidase gene (hdnO) from pAO1 (12, 13) and characterized its promoter region (hdnOp) (2). Recently, we also cloned the hdnO repressor gene (hnoR), biochemically characterized its gene product, and identified the inducer molecule for hdnO expression (20).
It has been reported previously that shuttle vectors, developed from cryptic plasmids of phylogenetically related species such as Corynebacterium glutamicum (22) and Brevibacterium lactofermentum (9), can also replicate in some Arthrobacter species, and some reports have previously described the cloning of genes in Arthrobacter species (10, 14, 21) using such plasmids.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Construction of pART2 and pART3 vectors and their derivatives
|
![]() View larger version (29K): [in a new window] |
FIG. 1. DNA maps of plasmids pART2 and pART3. The following plasmid features are presented: pCG100 and ColE1 origins of replication; Kanr, kanamycin resistance gene; P, promoter/operator of the hdnO gene (hdnOp); MCS; His8, eight-histidine tag coding sequence; and plasmid size in bp. Relevant restriction sites, including unique restriction sites, and bp positioning are represented. pART3 additionally carries the hdnO repressor gene (hnoR). The bottom sequence shows the following features: rbs, inferred ribosomal binding site; ATG, the translation start codon; MCS with nine unique restriction sites; coding sequence for a His8 tag; and TAA, translation stop codon. Note that the SalI* site is present twice in the pART3 vector. DNA analysis and map displays were prepared with BioEdit (7).
|
|
|
|---|
As shown in Fig. 2, A. nicotinovorans produces bright fluorescence when transformed with pART2-gfp (panel B).A. nicotinovorans containing plasmid pAO1 (A. nicotinovorans/pAO1) transformed with pART2-gfp produces slightly reduced fluorescence (panel C). This is explained by the presence of HnoR, produced from the pAO1 plasmid, which leads to the repression of hdnOp-driven gfp expression. The pART2 vector is designed for constitutive gene expression in Arthrobacter species, independent of the growth conditions. However, the expression of nicotine uptake and nicotine catabolic genes in A. nicotinovorans/pAO1 is poor in rich medium. Therefore, nicotine-inducible gene expression from the pART3 plasmid was carried out on citrate minimal medium. When A. nicotinovorans/pAO1 was transformed with pART3-gfp, no fluorescent bacteria were detectable under the fluorescence microscope (panel D). The presence of HnoR, produced from pART3 and additionally from pAO1, leads to efficient repression of hdnOp-driven gfp expression. The addition of nicotine to the cultures resulted in the induction of gfp expression, as demonstrated by the appearance in the cultures of fluorescent bacteria following 60 min of growth in the presence of nicotine (panel E) and an increased fluorescence of bacteria in cultures grown with nicotine overnight (panel F). The expression of gfp from the pART3 vector was also tested in A. globiformis, and we observed the appearance of nicotine- and 6-hydroxy-nicotine-dependent GFP fluorescence (data not shown). Cells induced with 6-hydroxynicotine expressed brighter fluorescence than those induced with nicotine, which is in agreement with the different induction efficiencies of the two compounds. These experiments demonstrate the functionality of pART vectors in A. nicotinovorans and other Arthrobacter spp. Nevertheless, not every species can be used as a host for nicotine-inducible expression from pART3, unless it has a nicotine uptake system. A. globiformis was described previously to degrade nicotine, and thereby it should have a nicotine uptake system (11).
![]() View larger version (12K): [in a new window] |
FIG. 2. Fluorescent A. nicotinovorans cells upon gfp expression. (A) Light microscopy image of A. nicotinovorans bacteria. Inset, magnified individual cell field. (B) Fluorescence microscopy image of A. nicotinovorans transformed with pART2-gfp; (C) A. nicotinovorans/pAO1 transformed with pART2-gfp; (D to F) A. nicotinovorans/pAO1 transformed with pART3-gfp and grown in the absence of nicotine (D), in the presence of nicotine for 60 min (E), and in the presence of nicotine overnight (F). Bacteria shown in panels A to C were grown in LB medium, and bacteria shown in panels D to F were grown in citrate medium supplemented with 0.5% yeast extract, mineral salts (5), and, as required, 0.05% L-nicotine. Pictures of A. nicotinovorans bacteria were taken using an Zeiss Axioskop 50 epifluorescence microscope equipped with a Plan-Nofluar 100x (1.3-numerical-aperture) objective and a triple-pass filter set. Digital images were recorded with a Nikon D100 camera.
|
|
|
|---|
18 U per mg protein, which corresponds to the previously reported specific activity of the enzyme (1). DhpH-His8 was also produced from A. nicotinovorans/pAO1 transformed with pART3-dhpH, grown in citrate minimal medium, and induced with nicotine (Fig. 3B). The yield of DhpH-His8 from A. nicotinovorans/pAO1 lysates was approximately 3%.
![]() View larger version (77K): [in a new window] |
FIG. 3. Purification of DhpH-His8 from A. nicotinovorans extracts. (A) Ni2+-chelating Sepharose affinity chromatography purification of DhpH-His8 from crude extracts of A. nicotinovorans transformed with pART2-dhpH and grown in LB medium without nicotine induction. Lane 1, crude extract; lane 2, purified protein fraction, eluted with 200 mM imidazole. (B) Ni2+-affinity purification of DhpH-His8 from extracts of A. nicotinovorans/pAO1 transformed with pART3-dhpH and grown in citrate minimal medium in the presence of 0.05% L-nicotine. Lane 1, crude extract; lane 2, purified protein fraction, eluted with 200 mM imidazole. The transformation of A. nicotinovorans with pART plasmids was achieved by electroporation with competent cells as described previously (6), with selection on kanamycin (140 µg ml1). E. coli was selected with 20 µg ml1 kanamycin.
|
We have proven in this work the functionality and usefulness of the pART2 and pART3 vectors for protein overproduction in Arthrobacter spp. These vectors are particularly valuable for the production of proteins, which cannot be produced in their active form in heterologous systems. These plasmids will be used to overproduce active nicotine dehydrogenase and ketone dehydrogenase for biochemical studies with their natural host, A. nicotinovorans. These enzymes are inactive when overproduced in E. coli (P. Sachelaru and R. Brandsch, unpublished) because the molybdopterin cytosine dinucleotide cofactor required for their activity is not made in E. coli, which instead synthesizes the molybdopterin guanine dinucleotide cofactor. In addition, these plasmids will be used as essential tools in genetic complementation studies with Arthrobacter spp.
|
|
|---|
We thank K. H. Gartemann, Bielefeld, Germany, for providing plasmid p25435.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»